72 evolution "https:" "https:" "https:" "https:" "https:" "https:" "U.S" uni jobs at DAAD
Sort by
Refine Your Search
-
Portal https://securemail.tu-dresden.de by sending it as a single pdf file to bu at mailbox.tu-dresden.de or to: TU Dresden, Chair of Business Administration esp. Sustainability Management and
-
of future immersive learning opportunities. Your tasks Technical development and implementation of a VR-based learning environment Integration of AI-driven learning modules Creation of industry-specific
-
(MultiACT)”. The project focuses on the development and implementation of a novel attosecond timing tool to be used in combination with an angular-resolved photoelectron detector. The setup will be installed
-
to contribute to sustainable development. To this end, scholarships are granted for development-related Master or doctoral studies for individuals who plan to pursue a career in teaching and / or research at a
-
theoretical models based on the latest development in the field maintain accurate and detailed records of all research activities and findings support the application for beamtime at suitable synchrotron
-
developing countries (KOSPIE)" with funds from the Federal Ministry for Economic Cooperation and Development (BMZ). As part of this programme, young students from Tunisia from engineering subjects (including a
-
to contribute to sustainable development. To this end, scholarships are granted for development-related Master or doctoral studies for individuals who plan to pursue a career in teaching and / or research at a
-
Description In the Department of Nuclear Medicine, we are interested in the development and clinical translation of molecular imaging tools for various applications, such as oncology, regenerative
-
well as professional and personal support. The scholarship holders are supported in their personal development with a large number of offers. This includes soft skill seminars and language courses as well as summer
-
/progenitor cells. A clinically active p300/CREBBP inhibitor is currently in development and is expected to enter clinical trials in late 2026. PhD project: Targeting p300/CREBBP to Enhance Interferon Signaling